Shares of DaVita Inc. /zigman2/quotes/204229673/composite DVA -0.60% shed 1.92% to $82.78 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.16% falling 0.21% to 3,647.29 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.0091% falling 0.43% to 29,134.99. This was the stock's sixth consecutive day of losses. DaVita Inc. closed $42.03 short of its 52-week high ($124.81), which the company reached on April 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Fresenius Medical Care AG & Co. KGaA ADR /zigman2/quotes/210057637/composite FMS +0.59% fell 2.82% to $13.76, Laboratory Corp. of America Holdings /zigman2/quotes/203174601/composite LH +0.60% fell 1.80% to $206.64, and Universal Health Services Inc. Cl B /zigman2/quotes/208539347/composite UHS +1.10% fell 2.31% to $87.81. Trading volume (512,446) remained 238,162 below its 50-day average volume of 750,608.